NewsDialy
Organic operational revenue strips out foreign-exchange swings and acquisition effects to show how fast a business is actually growing on its own.
(NYSE: ZTS), that measure turned negative in fiscal Q2 2026, falling 1%, even as total reported revenue held flat at $2.5 billion.
The animal-health company then cut its full-year 2026 revenue forecast to a range of $9.12 to $9.32 billion, down from its prior projection of $9.68 to $9.96 billion.
Where the business held Livestock was the clear source of strength. Zoetis reported a 12% increase in livestock revenue on a reported basis, with U.S. livestock sales climbing 23% on both reported and organic measures.
Keep reading